M&A

Asia
Pharma

China's BCI nod, AZ, Astellas—Fierce Pharma Asia

China approved the world's first commercial brain-computer interface. AZ expands cell therapy capabilities in China. Astellas ended a bispecific deal.
Angus Liu Mar 20, 2026 8:00am
A chessboard with blocks that read MA

Corium sells off ADHD drug Azstarys to Collegium for $650M-plus

Mar 19, 2026 11:27am
Board room C-suite meeting contract

Sanofi sells generics unit to Brazil's EMS

Mar 6, 2026 2:00pm
Servier

Servier rounds out rare cancer offerings with $2.5B Day One buy

Mar 6, 2026 10:14am
manufacturing drug manufacturing pharma manufacturing assembly line

Forma Life Sciences launches into class of new CDMOs

Mar 5, 2026 12:42pm
MA

Esperion pays $75M for Corstasis and FDA-approved nasal spray

Mar 3, 2026 8:40am